在诱导免疫化疗后取得主要病理反应的局部晚期食管鳞状细胞癌患者中,放疗作为器官保存替代手术。

IF 4.7 2区 医学 Q1 ONCOLOGY
Xin-Yun Song, Lin Lin, Yang Yang, Hui-Hui Hu, Hong-Xuan Li, Wen Feng, Qin Zhang, Xu-Wei Cai, Xiao-Long Fu, Zhi-Gang Li, Jun Liu, Wen Yu
{"title":"在诱导免疫化疗后取得主要病理反应的局部晚期食管鳞状细胞癌患者中,放疗作为器官保存替代手术。","authors":"Xin-Yun Song, Lin Lin, Yang Yang, Hui-Hui Hu, Hong-Xuan Li, Wen Feng, Qin Zhang, Xu-Wei Cai, Xiao-Long Fu, Zhi-Gang Li, Jun Liu, Wen Yu","doi":"10.1002/ijc.35515","DOIUrl":null,"url":null,"abstract":"<p><p>With the advancement of immunotherapy, neoadjuvant immunochemotherapy has emerged as an effective approach for treating locally advanced esophageal squamous cell carcinoma (LA-ESCC). However, whether radiotherapy can serve as a reliable organ-preserving alternative following induction immunochemotherapy (IICT), and which patient subgroups benefit most, remains uncertain. In this retrospective study, 388 patients with LA-ESCC were analyzed, including 299 who underwent surgery and 89 who received radiotherapy after IICT. Responses to immunochemotherapy were classified as major pathologic response (MPR) or non-MPR based on pathologic examination for surgical patients and a previously developed MPR predictive model for radiotherapy patients. Survival outcomes were assessed using the Kaplan-Meier method, while prognostic factors were evaluated through Cox regression analyses. Propensity score matching (PSM) was used to minimize confounding factors. Surgery was associated with better progression-free survival (PFS) compared to radiotherapy (p = 0.002 before PSM; p = 0.017 after PSM), but no significant difference in overall survival (OS) was observed (p = 0.144 before PSM; p = 0.241 after PSM). Among MPR patients, radiotherapy achieved PFS and OS outcomes similar to surgery (PFS: p = 0.136; OS: p = 0.255) after PSM. Failure patterns differed, with local or regional recurrence being more common in the radiotherapy group, while distant metastasis was prevalent in surgery patients. Major postoperative complications occurred in 9.36% of surgery patients, and 11.2% of radiotherapy patients had grade 3-4 adverse events. These findings indicate that radiotherapy could be a safe and effective organ-preserving alternative for LA-ESCC patients, especially those achieving MPR, offering more personalized and less invasive treatment options while maintaining quality of life.</p>","PeriodicalId":180,"journal":{"name":"International Journal of Cancer","volume":" ","pages":""},"PeriodicalIF":4.7000,"publicationDate":"2025-06-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.\",\"authors\":\"Xin-Yun Song, Lin Lin, Yang Yang, Hui-Hui Hu, Hong-Xuan Li, Wen Feng, Qin Zhang, Xu-Wei Cai, Xiao-Long Fu, Zhi-Gang Li, Jun Liu, Wen Yu\",\"doi\":\"10.1002/ijc.35515\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>With the advancement of immunotherapy, neoadjuvant immunochemotherapy has emerged as an effective approach for treating locally advanced esophageal squamous cell carcinoma (LA-ESCC). However, whether radiotherapy can serve as a reliable organ-preserving alternative following induction immunochemotherapy (IICT), and which patient subgroups benefit most, remains uncertain. In this retrospective study, 388 patients with LA-ESCC were analyzed, including 299 who underwent surgery and 89 who received radiotherapy after IICT. Responses to immunochemotherapy were classified as major pathologic response (MPR) or non-MPR based on pathologic examination for surgical patients and a previously developed MPR predictive model for radiotherapy patients. Survival outcomes were assessed using the Kaplan-Meier method, while prognostic factors were evaluated through Cox regression analyses. Propensity score matching (PSM) was used to minimize confounding factors. Surgery was associated with better progression-free survival (PFS) compared to radiotherapy (p = 0.002 before PSM; p = 0.017 after PSM), but no significant difference in overall survival (OS) was observed (p = 0.144 before PSM; p = 0.241 after PSM). Among MPR patients, radiotherapy achieved PFS and OS outcomes similar to surgery (PFS: p = 0.136; OS: p = 0.255) after PSM. Failure patterns differed, with local or regional recurrence being more common in the radiotherapy group, while distant metastasis was prevalent in surgery patients. Major postoperative complications occurred in 9.36% of surgery patients, and 11.2% of radiotherapy patients had grade 3-4 adverse events. These findings indicate that radiotherapy could be a safe and effective organ-preserving alternative for LA-ESCC patients, especially those achieving MPR, offering more personalized and less invasive treatment options while maintaining quality of life.</p>\",\"PeriodicalId\":180,\"journal\":{\"name\":\"International Journal of Cancer\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":4.7000,\"publicationDate\":\"2025-06-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1002/ijc.35515\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Cancer","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/ijc.35515","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

随着免疫疗法的发展,新辅助免疫化疗已成为治疗局部晚期食管鳞状细胞癌(LA-ESCC)的有效方法。然而,放疗是否可以作为诱导免疫化疗(IICT)后可靠的器官保存替代方案,以及哪些患者亚组受益最大,仍不确定。在这项回顾性研究中,分析了388例LA-ESCC患者,其中299例接受手术,89例接受IICT后放疗。根据手术患者的病理检查和先前开发的放疗患者的MPR预测模型,将免疫化疗的反应分为主要病理反应(MPR)或非MPR。生存结果采用Kaplan-Meier法评估,预后因素采用Cox回归分析评估。倾向评分匹配(PSM)用于最小化混杂因素。与放疗相比,手术与更好的无进展生存(PFS)相关(PSM前p = 0.002;PSM后p = 0.017),但总生存期(OS)无显著差异(p = 0.144;PSM后p = 0.241)。在MPR患者中,放疗获得的PFS和OS结果与手术相似(PFS: p = 0.136;OS: p = 0.255) PSM后。失败模式不同,局部或区域复发在放疗组更为常见,而远处转移在手术患者中普遍存在。9.36%的手术患者出现术后重大并发症,11.2%的放疗患者出现3-4级不良事件。这些研究结果表明,对于LA-ESCC患者,特别是那些实现MPR的患者,放射治疗可能是一种安全有效的器官保存选择,在保持生活质量的同时提供更个性化和更少侵入性的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Radiotherapy as an organ-preserving alternative to surgery in patients with locally advanced esophageal squamous cell carcinoma achieving major pathologic response after induction immunochemotherapy.

With the advancement of immunotherapy, neoadjuvant immunochemotherapy has emerged as an effective approach for treating locally advanced esophageal squamous cell carcinoma (LA-ESCC). However, whether radiotherapy can serve as a reliable organ-preserving alternative following induction immunochemotherapy (IICT), and which patient subgroups benefit most, remains uncertain. In this retrospective study, 388 patients with LA-ESCC were analyzed, including 299 who underwent surgery and 89 who received radiotherapy after IICT. Responses to immunochemotherapy were classified as major pathologic response (MPR) or non-MPR based on pathologic examination for surgical patients and a previously developed MPR predictive model for radiotherapy patients. Survival outcomes were assessed using the Kaplan-Meier method, while prognostic factors were evaluated through Cox regression analyses. Propensity score matching (PSM) was used to minimize confounding factors. Surgery was associated with better progression-free survival (PFS) compared to radiotherapy (p = 0.002 before PSM; p = 0.017 after PSM), but no significant difference in overall survival (OS) was observed (p = 0.144 before PSM; p = 0.241 after PSM). Among MPR patients, radiotherapy achieved PFS and OS outcomes similar to surgery (PFS: p = 0.136; OS: p = 0.255) after PSM. Failure patterns differed, with local or regional recurrence being more common in the radiotherapy group, while distant metastasis was prevalent in surgery patients. Major postoperative complications occurred in 9.36% of surgery patients, and 11.2% of radiotherapy patients had grade 3-4 adverse events. These findings indicate that radiotherapy could be a safe and effective organ-preserving alternative for LA-ESCC patients, especially those achieving MPR, offering more personalized and less invasive treatment options while maintaining quality of life.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
13.40
自引率
3.10%
发文量
460
审稿时长
2 months
期刊介绍: The International Journal of Cancer (IJC) is the official journal of the Union for International Cancer Control—UICC; it appears twice a month. IJC invites submission of manuscripts under a broad scope of topics relevant to experimental and clinical cancer research and publishes original Research Articles and Short Reports under the following categories: -Cancer Epidemiology- Cancer Genetics and Epigenetics- Infectious Causes of Cancer- Innovative Tools and Methods- Molecular Cancer Biology- Tumor Immunology and Microenvironment- Tumor Markers and Signatures- Cancer Therapy and Prevention
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信